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Skeletal muscle development occurs asynchronously and it has been proposed to be dependent upon the generation of temporally distinct
populations of myogenic cells. This long-held hypothesis has not been tested directly due to the inability to isolate and analyze purified populations
of myoblasts derived from specific stages of prenatal development. Using a mouse strain with the GFP reporter gene targeted into theMyf5 locus, a
cell-sorting method was developed for isolating embryonic and fetal myoblasts. The two types of myoblasts show an intrinsic difference in fusion
ability, proliferation, differentiation and response to TGFβ, TPA and BMP-4 in vitro. Microarray and quantitative PCR were used to identify
differentially expressed genes both before and after differentiation, thus allowing a precise phenotypic analysis of the two populations. Embryonic
and fetal myoblasts differ in the expression of a number of transcription factors and surface molecules, which may control different developmental
programs. For example, only embryonic myoblasts express a Hox code along the antero-posterior axis, indicating that they possess direct positional
information. Taken together, the data presented here demonstrate that embryonic and fetal myoblasts represent intrinsically different myogenic
lineages and provide important information for the understanding of the molecular mechanisms governing skeletal muscle development.
© 2007 Elsevier Inc. All rights reserved.Keywords: Embryonic myoblast; Fetal myoblast; Microarray; Hox; TGFβ; Notch; Fiber diversityIntroduction
All the skeletal muscles in vertebrate body (with the
exception of some craniofacial muscles) derive from progenitors
present in the somites (Gossler and Hrabe-DeAngelis, 1998),
transient mesodermal units, which form in a cranio-caudal
succession by segmentation of the paraxial mesoderm. Each
newly formed somite rapidly differentiates into a ventral scle-⁎ Corresponding author. Stem Cell Research Institute, Dibit, H. San Raffaele,
via Olgettina 58, 20132 Milan, Italy. Fax: +39 02 2643 4621.
E-mail address: cossu.giulio@hsr.it (G. Cossu).
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doi:10.1016/j.ydbio.2007.01.016rotome and a dorsal dermomyotome from which myogenic
precursors originate. Skeletal muscle is formed in successive
distinct, though overlapping steps involving different myoblast
populations (Tajbakhsh, 2005). The first multinucleated muscle
fibers that appear in the embryo are called primary fibers, and are
formed by embryonic myoblasts which differentiate by fusing
with each other. This phase, which is usually referred to as
primary myogenesis takes place at approximately E10.5–12.5 in
the mouse. Only a fraction of myogenic progenitors terminally
differentiate during primary myogenesis. The remaining are kept
in a committed (likely depending upon Pax3/Pax7 expression
(Kassar-Duchossoy et al., 2005; Relaix et al., 2005)), but
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place between E14.5 and E17.5. This latter phase is called
secondary myogenesis and depends upon fusion of fetal
myoblasts to give rise to secondary fibers (originally smaller
and surrounding primary fibers (Kelly and Zacks, 1969)). Fetal
myoblasts have also been proposed to fuse in part with primary
fibers (Zhang and McLennan, 1995). From E16.5, satellite cells
can be morphologically identified as mononucleated cells lying
between the basal lamina and the fiber plasma membrane
(Mauro, 1961). They are responsible for postnatal growth and
repair of skeletal muscle.
Work from a number of laboratories, including our own,
identified specific features of embryonic and fetal myoblasts,
and satellite cells, that characterize them as distinct classes of
myogenic cells (Cossu and Biressi, 2005; Cossu and Molinaro,
1987; Miller et al., 1999). Embryonic and fetal myoblasts,
thought to generate primary and secondary fibers respectively,
differ in the morphology of the myotubes they generate in vitro,
and in the myosin heavy chains isoforms and muscle enzymes
that they express (Barbieri et al., 1990; Bonner and Hauschka,
1974; Ferrari et al., 1997; Pin and Merrifield, 1993; Zappelli et
al., 1996). They also differ with respect to media requirements
(White et al., 1975), integrin–extracellular matrix interactions
(Blanco-Bose and Blau, 2001), resistance to inhibitors of
myogenesis such as phorbol esters (Cossu et al., 1988) and
TGFβ (Cusella-DeAngelis et al., 1994). Previous studies have
been limited by the heterogeneity of the populations analyzed,
since no markers or methods were available to isolate pure
populations of murine embryonic and fetal myoblasts. As
myoblasts represent only a minority of the cells that comprise
the embryonic and fetal mesoderm, it was always possible that
any differences observed in vitro may simply be due to
differences in the signals from neighboring cells. Even the
reported asynchrony of fusion into primary and secondary fibers
could simply be the consequence of a stochastic process. Thus,
the first cells to differentiate within an asynchronous population
fuse into myotubes that then secrete growth factors such as
bFGF. bFGF could cause a second wave of proliferation in those
myoblasts, which, by chance, had not yet become post-mitotic.
Moreover, the inability to isolate and work with pure population
of embryonic and fetal myoblasts has so far prevented any
detailed phenotypic analysis.
In this study, a cell-sorting method for isolating embryonic
and fetal myoblasts was developed using a mouse strain with the
GFP gene targeted into one allele of the Myf-5 locus (Kassar-
Duchossoy et al., 2004), allowing fluorescence activated cell
sorting (FACS) of embryonic and fetal myoblast populations.
We now show that highly purified embryonic and fetal myo-
blasts differ in proliferation, differentiation, fusion ability and
sensitivity to inhibitors of myogenesis (TGFβ, TPA, BMP-4) in
vitro. The molecular mechanisms responsible for this myoblast
diversification were explored by using microarray analysis and/
or real-time PCR on purified populations of myoblasts. This
approach revealed a number of genes that are differentially
expressed both before and after differentiation, in the two
populations. These include several genes which are known to be
involved in skeletal muscle development and physiology such asPax3, Paraxis, Muscle Creatin Kinase, Integrin α-7 and PkCθ.
Interestingly, a Hox code is expressed along the antero-posterior
axis specifically in embryonic but not in fetal myoblasts.
Moreover, embryonic and fetal myotubes selectively express
genes characteristic of adult slow and fast contracting fibers,
respectively. Together, these results demonstrate that embryonic
and fetal myoblasts represent intrinsically different myogenic
lineages and open the possibility to explore the molecular
mechanisms responsible for myoblast diversification.Materials and methods
Cell isolation
Myf5GFP-P mice were produced by targeting the gene encoding enhanced
Green Fluorescent Protein (GFP) into the Myf5 locus (Kassar-Duchossoy et al.,
2004). Where indicated, heterozygous Myf5GFP-P/+ mice were crossed with
wild-type (wt) mice or homozygous Tg:3F-nlacZ-2E transgenic mice that
express a transgene encoding nuclear-localizing β-galactosidase under the
transcriptional control of the myosin light chain 1/3-fast promoter, expression
which is restricted to terminally differentiated skeletal and cardiac muscle (Kelly
et al., 1995).
Embryonic myoblasts were isolated from E11.5 (or E10.5 for purification
from different axial levels) embryos; fetal myoblasts from E16.5 Myf5GFP-P/+
mice.Myf5GFP-P/+ embryos and fetuses were distinguished from their wild-type
littermates by examination under a fluorescence microscope. Embryonic
myoblasts were obtained from the somites and limbs of E11.5 embryos; fetal
myoblasts from E16.5 fetuses after removal of the head, internal organs and skin
to enrich for myoblasts in the dissociated cell preparation. Tissues were
dissociated with 0.15 mg/ml collagenase Type V (Sigma), 0.4 mg/ml dispase
(Gibco), 0.1 mg/ml Dnase I (Roche) in a buffered solution (Hank's Balanced
Salt Solution (HBSS; BioWhittaker) supplemented with 15 mMHEPES, 15 mM
glucose, 1.5 mM MgSO4, 0.3% (W/V) bovine serum albumin (BSA), pH 7.4).
When embryonic myoblasts were isolated from different axial levels of E10.5
embryos, the limb buds were removed to avoid contamination with limb
myoblasts.
Dissociated cells were resuspended in DMEM–high glucose (Gibco),
supplemented with 20% fetal calf serum (FCS; BioWhittaker), 20 mM HEPES
and 2 mM EDTA and filtered through 40-μm cell strainers (Falcon) before
sorting using a Vantage Sorter SE (Becton-Dickinson) at a flow rate of 3000
cells per second. GFP was exited at 488 nm using an argon laser. Specific green
fluorescence, forward (FSC) and side (SSC) light scatter were measured. FSC
and SSC parameters were used to gate out cell clumps and debris. Cells
dissociated from wild-type littermates were used to set the gating to exclude
green autofluorescence. The purity of each sorted sample was evaluated by
immediate reanalyzing of approximately 10,000 cells.
The cell cycle progression of the GFP-positive and GFP-negative cells was
analyzed by FACS after Hoechst staining. Cells were incubated for 90 min at
37 °C in 5 μg/ml Hoechst 33342 (Sigma), pelleted and maintained at 4 °C before
FACS analysis. PE-conjugated anti-mouse CD45 antibodies or mouse IgG1, k
immunoglobulins (isotypic control) (Pharmingen) were used to evaluate the
presence of CD45 in the GFP-positive cells.
All experiments were performed under internal regulations for animal care
and handlings.
Cell culture
For the differentiation assay, sorted embryonic and fetal myoblasts were
resuspended in DMEM–high glucose supplemented with 20% horse serum
(BioWhittaker) and 20 mMHEPES and spotted onto calf skin collagen (Sigma)-
coated dishes, at a density of approximately 80,000 cells/cm2. Where indicated,
TGFβ-1 (10 ng/ml; Sigma), human recombinant BMP-4 (50 ng/ml; RD), TPA
(1 μM; Calbiochem) and L-685,458 (1 μM; Sigma) were added to the media 4 h
after plating and re-added every 24 h. Each day, half of the medium was replaced
with fresh medium.
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E11.5 and E16.5 mice were plated at clonal density (approximately 200 cells/
cm2) and cultured in DMEM–high glucose supplemented with 20% horse serum
(BioWhittaker), 20 mM HEPES and 3% chicken embryo extract for 3 days. The
myogenic properties of the colonies were verified by staining with anti-MyoD
and anti-desmin antibodies.
To evaluate the response to regulatory molecules, C2C12 (ATCC) myoblasts
were plated at 20,000 cells/cm2 in DMEM–high glucose supplemented with
10% fetal calf serum. One and two days after plating, the medium was replaced
with DMEM–high glucose supplemented with 2% fetal calf serum (FCS) to
induce differentiation. TGFβ-1, TPA and BMP-4 were added to the medium the
day after plating and re-added every 24 h, as previously described for embryonic
and fetal myoblasts.
Immunofluorescence/β-Galactosidase staining
Cell cultures were fixed in 4% paraformaldehyde for 10 min at 4 °C. For β-
galactosidase staining cells were incubated at 37 °C for 5 h in X-Gal buffer
(1 mg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactosidase, 5 mM K4Fe(CN)
6,
5 mM K3Fe(CN)
6, 2 mM MgCl2 in PBS). For BrdU incorporation assays, cells
were incubated with 50 μm BrdU (Sigma) in complete medium for 1 h, washed,
fixed in a 95% ethanol/5% (V/V) acetic acid solution for 20 min and then treated
with 1.5 M HCl for 10 min at room temperature. Immunofluorescent staining
was carried out using the following antibodies: rabbit anti-all sarcomeric myosin
heavy chains (MyHCs) (Minasi et al., 2002); rabbit anti-GFP (Molecular
Probes); rabbit anti-desmin (Sigma); mouse anti-MyoD (clone 5.8A, DakoCy-
tomation); mouse anti-BrdU (Amersham); mouse anti-myogenin (F5D, kindly
provided by Dr. W.E. Wright). Preparations were blocked with 10% donkey
serum at room temperature for 30 min and then incubated at 4 °C overnight with
primary antibodies in PBS containing 1% BSA and 0.2% Triton. Preparations
were then washed with PBS and incubated for 1 h at room temperature with
Alexa Fluor 594-conjugated, donkey anti-rabbit IgG or Alexa Fluor 488-
conjugated, donkey anti-mouse antibodies (Molecular Probes). Finally,
preparations were washed and mounted in Vectashield mounting medium
containing DAPI (Vector Lab Inc.). In some experiments Hoechst was used to
stain the nuclei instead of DAPI.
The number of cells containing LacZ expressing nuclei, GFP, MyHCs-,
myogenin- or desmin-positive cells and total nuclei were counted in at least 3
microscopic fields at 10× magnification and 6 microscopic fields at 20×
magnification for each replicate. Data were obtained from 2–4 independent
experiments run in duplicate. To determine the colony forming ability, the
number of MyoD+ and desmin+ cells in each myogenic clone was quantified. At
least 50 myogenic clones were counted in each experiment. Data were obtained
from 3 separate experiments. Data were analyzed using unpaired Student's
t-tests.
Microarray analysis
Purified embryonic and fetal myoblasts were stored at −80 °C and pooled
together for total RNA extraction. Total cellular RNA was isolated from cell
populations using RNeasy RNA isolation kit (Qiagen) following manufacturer's
recommendations. Disposable RNA chips (Agilent RNA 6000 Nano LabChip
kit) were used to determine the concentration and purity/integrity of RNA
samples using Agilent 2100 bioanalyzer. C2C12 myoblasts were grown in
DMEM–high glucose supplemented with 10% fetal calf serum and processed
for RNA extraction in the same way. For each population, 5 μg of total RNAwas
used for cDNA synthesis. cDNA synthesis, biotin-labeled target synthesis,
MOE430A and B GeneChip (Affymetrix) arrays hybridization, staining and
scanning were performed according to the standard protocol supplied by
Affymetrix. The amount of a transcript mRNA (signal) was determined by the
Affymetrix Microarray Suite software (MAS 5.0) absolute analysis algorithm as
already described (Liu et al., 2002). All expression values for the genes in the
MAS 5.0 absolute analyses were determined using the global scaling option.
Pair-wise analyses between samples were performed usingMAS 5.0 comparison
analysis algorithm. Microarray experiments have been submitted to GEO in a
MIAME compliant format (Minimum Information About a Microarray
Experiment) (Brazma et al., 2001). The accession numbers are GSM124899,
GSM124900, GSM124901, GSM124902, GSM124903 and GSM124904.Microarray data, along with the MIAME checklists have been submitted as
Supplementary material.
The processed data were further examined using Microsoft Excel. Low
values were arbitrarily reassigned threshold values of 50 for purposes of
calculating fold changes. Subsequently, probe sets with fold change of greater
than 3 and with Gene Ontology biological and/or molecular function and/or
cellular localization term were used to compare embryonic data (baseline)
against fetal myoblasts and C2C12. Excel files with numeric expression values,
qualitative absent (A)/marginal (M)/present (P) call values and relative fold
induction accompanies the manuscript (Supplementary Tables 5 and 6). These
genes were hierarchically clustered using the gplots library of the R software
(http://www.R-project.org). Hierarchical clustering of both genes and samples
was performed using Pearson correlation as similarity measure (Fig. 6B).
Using the Affymetrix software GObrowser (http://www.affymetrix.com),
the numbers of probe sets on Mouse Expression Array 430 A and B GeneChip
corresponding to the Gene Ontology (GO) terms ‘Transcription’ (GOID: 6350),
‘Cell adhesion molecules’ (GOID: 7155), ‘Pattern specification’ (GOID: 7389),
‘Embryonic development’ (GOID: 9790) and ‘Signal transduction’ (GOID:
7165) were calculated as of the November 2005 annotation build. Percentiles for
each GO term category were calculated by dividing the numbers in each
category by the total number of probe sets with an annotated GO biological
function (Fig. 6C).
Quantitative real-time polymerase chain reaction
RNAwas extracted and quantified as described above. cDNAs were reverse
transcribed from total RNA samples (100 ng per sample) using High Capacity
cDNA Archive Kit (Applied Biosystems) as described in the manufacturer's
protocol. TaqMan PCR reactions were carried out from cDNA samples using
custom TaqMan low density arrays (Applied Biosystems) by means of ABI
PRISM 7900 HT Sequence Detection Systems. Gene expression profiling was
achieved using the Comparative CT method of relative quantification.
Results
Purification of embryonic and fetal myoblasts from
Myf5GFP-P/+ mice
To obtain pure populations of embryonic and fetal myoblasts,
GFP-expressing cells were isolated by FACS from cellular
suspensions obtained from Myf5GFP-P/+ mice at E11.5 and
E16.5, respectively (Cossu et al., 1988). Myf5 is the first of the
myogenic regulatory factors to be expressed in proliferating
myoblasts and its regulatory sequences drive the expression of
the reporter gene in cells entering the myogenic lineage
(Tajbakhsh et al., 1996). Since this study aimed to investigate
phenotypically normal embryonic and fetal myoblasts, cells
were isolated from heterozygous mice in which the presence of a
single functional Myf5 allele is sufficient to drive normal
myogenesis (Tajbakhsh et al., 1996). Approximately 1–2% of
the cells obtained from the mesoderm digest of both E11.5 and
E16.5 mice expressed GFP (Figs. 1A, C). It was therefore
possible to sort 10,000–15,000 cells from each E11.5 embryo
and 3–4 times as many cells from each E16.5 fetus. Both sorted
populations presented an overall purity of more than 95%
(respectively 95.8±1.9 and 95.5±2.1 for E11.5 and E16.5)
when reanalyzed by FACS immediately after sorting (Figs. 1B,
D; Supplementary Table 3) and greater than 98% (respectively
98.9±1.8 and 98.1±1.0 for E11.5 and E16.5) when assayed with
anti-GFP antibodies after 8 h of culture (Supplementary Figs.
11A–D). To demonstrate that cells sorted from Myf5GFP-P/+
mice were indeed myogenic, immunofluorescent staining with
Fig. 1. Efficient isolation of embryonic and fetal myoblasts from cellular digestions obtained fromMyf5GFP-P/+ mice at E 11.5 (A, C) and E 16.5 (B, D), respectively.
(A, C) GFP-expressing cells are separated in two-dimensional dot plot of GFP (abscissa) and intrinsic SSC (ordinate). Forward scatter and side scatter were previously
used to gate out cell clumps and debris from the total initial population and green autofluorescence was evaluated on preparations obtained from wild-type mice at the
same stage (not shown). (C, D) An immediate reanalysis of the sorted populations by FACS confirmed the high degree of purity obtained (>95% of cells are GFP+).
Almost all the cells sorted fromMyf5GFP-P/+ embryos (G) and fetuses (H) express myogenic markers, as assayed by immunofluorescence with anti-desmin antibodies
after 3 days of culture. In contrast, unsorted embryonic (E) and fetal (F) populations contain only a small fraction of myoblasts. Dapi was used to stain nuclei. Scale
bar,100 μm. (I, L) The cell cycle progression of the GFP-positive cells (myoblasts; green) was analyzed by FACS after Hoechst staining and was compared with the
corresponding GFP negative fraction (red). For both embryonic (I) and fetal population (L), GFP-expressing cells present an enhanced number of cells in replicative
phases (S+G2+M phase).
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performed on both purified embryonic and fetal cell populations
after 8 h (Supplementary Figs. 11E–H) and 3 days (Figs. 1G, H)
of differentiation in vitro. At any time almost all (>98%) the
sorted cells expressed desmin, whereas unsorted populations
contained only a small fraction of muscular cells (∼20% after
3 days in vitro; Figs. 1E, F).
The cell cycle status of the GFP-positive myoblasts was
analyzed by FACS after Hoechst staining and was compared
with that one of the corresponding GFP-negative fractions,
consisting mainly of fibroblasts (Figs. 1I, L). For both
embryonic and fetal populations, a large proportion (33 and
32% respectively) of the GFP-expressing cells compared with
the GFP-negative cells, was in the S+G2+M phases of the cell
cycle, suggesting that both types of myoblasts were proliferat-
ing at the moment of isolation.
Phenotypic characterization of purified embryonic and fetal
myoblast cultures
Previous studies identified several phenotypic differences
between embryonic and fetal myoblasts. However, because
heterogeneous populations were studied, these differences
could result from signals coming from the surrounding cells
rather than intrinsic proprieties of the two populations of
myoblasts. To investigate in vitro differentiation, pure popula-
tions of embryonic and fetal myoblasts were obtained from
Myf5GFP-P/+//Tg:3F-nlacZ-2E mice (see Materials and meth-
ods) as in these mice, β-galactosidase expression is under the
control of myosin light chain 3F regulatory sequences and thus
restricted to differentiated, striated muscle cells. When cultured
under conditions that promote differentiation, purified embryo-nic and fetal myoblasts generated differentiated cells with
dramatically different morphologies. After 3 days in vitro,
embryonic cultures contained mononucleated differentiated
myocytes, usually aligned with each other (∼28% of total
differentiated cells) and multinucleated myotubes containing
only a few nuclei (<20) (Figs. 2A and E). At later times,
embryonic cultures contained large, morphologically abnormal
multinucleated cellular structures, which rapidly collapsed and
detached from the dish (Fig. 2B). In contrast, after 3 days, fetal
cultures contained larger myotubes than the embryonic cultures
with significantly more nuclei in large clusters in the center of
the myotubes (21.6% of total differentiated nuclei were in
myotubes with ≥20 nuclei) (Figs. 2C and E). After 6 days in
culture, the fetal myotubes were larger with greater numbers of
ramifications (Fig. 2D; data not shown). Moreover sponta-
neously contracting fetal myotubes were common, whereas
contracting embryonic myotubes were almost never observed,
suggesting that the molecular mechanisms regulating the
excitation, contraction or adhesion should be different in the
two populations.
To determine if murine embryonic and fetal myoblasts could
fuse to each other, pure populations of embryonic and fetal
myoblasts were obtained respectively from Myf5GFP-P/+//
Tg:3F-nlacZ-2E and Myf5GFP-P mice, mixed in 1:1 proportion
and cultured for 3 days in vitro. The presence of MyHCs+
myotubes containing both β-galactosidase-positive and
-negative nuclei indicated that the two classes of myoblasts
can fuse with each other (Supplementary Figs. 12A, A′).
Nevertheless, when the number of myotubes containing both β-
galactosidase-positive and -negative nuclei (heterotypic myo-
tubes) was counted and compared with the number of myotubes
containing exclusively β-galactosidase-positive or -negative
Fig. 3. Embryonic and fetal myoblast show an intrinsically different proliferative
capacity and colony formation ability in vitro. Immunofluorescence with anti-
MyoD and anti-desmin antibodies (A, C) of representative clones of embryonic
(A, B) and fetal (C, D) myoblasts after 3 days of expansion in vitro. Hoechst was
used to stain nuclei (B, D). (E) The average number of MyoD+ cells per clone
was quantified. (F) Purified embryonic and fetal myoblast (Mb) were treated
with a pulse of BrdU 1 day after isolation and the percentage of cells in
proliferative state was counted. Bars represent±SD. *p<0.05, ***p<0.001.
Fig. 2. Purified embryonic and fetal myoblasts show a different morphology and
fusion ability in vitro. Phase contrast micrographs of embryonic myoblasts after
3 days (A) and 6 days (B), fetal myoblasts after 3 (C) and 6 days (D) in culture,
obtained from Myf5GFP-P/+//Tg:MLC3F-nlacZ-2E mice (see Materials and
methods), expressing β-galactosidase in the nuclei of differentiated muscle.
Note that embryonic myoblasts differentiate into mononucleated myocytes or
myotubes with few nuclei whereas fetal myotubes are longer and contain
numerous nuclei. After 6 days, branched myotubes were observed only in the
fetal population, whereas the embryonic population forms enlarged cellular
structures, which rapidly collapse detaching from the Petri dish (asterisk). Scale
bar, 50 μm. (E) The fusion ability was quantified by counting the number of
terminally differentiated nuclei contained in myotubes of different size (1–5, 5–
10, 11–20 and >20 nuclei). After 3 and 6 days fetal myotubes contain more
nuclei than embryonic myotubes. Bars represent±standard deviation (SD).
*p<0.05 vs. embryonic.
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frequently than expected for a stochastic process (Supplemen-
tary Figs. 12A, A′ and B). These observations suggest that
under our experimental conditions embryonic and fetal myo-
blast, although able to fuse to each other, are predisposed to fuse
with myoblasts of the same type with higher affinity.
When embryonic and fetal myoblasts were plated at clonal
density under conditions that promote proliferation (see
Materials and methods), the average number of cells per clone
differed dramatically between the two preparations. Embryonic
myoblasts generated smaller colonies (2.5±1.0 vs. 10.3±3.1
MyoD+ and 2.9±1.3 vs. 11.4±4.6 desmin+ cells/myogenic
colony from embryonic and fetal populations, respectively),
demonstrating that the two populations have different clono-genic potency in vitro (Fig. 3). To determine the percentage of
cells in the S phase of the cell cycle in the two populations,
embryonic and fetal myoblasts purified from the Myf5GFP-P/+
mice were pulsed with BrdU 1 day after plating. A larger
proportion (44.7±3.1%) of fetal myoblasts incorporated BrdU
in comparison with the embryonic population (37.3±3%), even
though the difference was far less dramatic than that observed in
the clonal analysis (Fig. 3F). To examine whether the different
proliferation potency correlates with the timing of differentia-
tion in vitro, embryonic and fetal myoblasts were maintained in
culture for 8 h and then stained for the expression of the
differentiation markers, myogenin and sarcomeric myosin
heavy chains (MyHCs). A greater percentage of embryonic
myoblasts expressed myogenin (38.9±3.6%) and myosin
(33.8±6.2%) in comparison with the fetal population (27.3±
1.3% and 17.5±3.7% for myogenin and myosin, respectively)
(Fig. 4), indicating that the reduced proliferation observed in
populations of embryonic myoblasts in vitro is associated with
an increased tendency towards differentiation.
Fig. 4. Embryonic myoblasts are more prone to differentiation than fetal myoblasts. Embryonic (A, B) and fetal (C, D) myoblasts purified fromMyf5GFP-P/+mice were
grown for 8 h in vitro. Immunostaining with antibodies which recognize myogenin (A, C) and all sarcomeric MyHCs (B, D) was performed. Note that the green
staining corresponding to myogenin has a nuclear localization and cannot be confused with the cytoplasmic GFP expressed under the control of the Myf5 regulatory
sequences. Dapi was used to stain nuclei. Scale bar, 100 μm. The number of myogenin+ (E) and MyHCs+ (E) cells was quantified on cells grown in proliferation
medium and expressed as percentage of total cell number. Bars represent±SD. *p<0.05.
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(Cossu et al., 1988; Cusella-DeAngelis et al., 1994) inhibit fetal,
but not embryonic myoblast differentiation. Those studies were
carried out using unpurified myoblast preparations. To test
whether TGFβ-1 and TPA act directly on embryonic and fetal
myoblasts, purified populations of embryonic, fetal and C2C12
myoblasts were treated with TGFβ-1, TPA or BMP-4 (which
has been reported to inhibit differentiation of satellite cells and
C2C12 myoblasts (Dahlqvist et al., 2003)). The degree of
differentiation in treated and control cultures was evaluated by
counting the percentage of nuclei contained in terminally
differentiated (i.e., sarcomeric MyHC-positive) cells. Fetal
myoblasts (Figs. 5B, B′, B″, B‴) and C2C12 (Figs. 5C, C′,
C″, C‴) were significantly more sensitive to all the factors
tested in comparison with embryonic myoblasts (Fig. 5A, A′,
A″, A‴). However, whereas embryonic myoblast differentiation
was completely unaffected by TGFβ-1 (Fig. 5D′), TPA (Fig.
5D″) and BMP-4 (Fig. 5D‴) had a modest but detectable effect.
Thus while fetal myoblasts and C2C12 myoblasts show similar
responses to TGFβ-1, TPA and BMP-4, both populations are
intrinsically different from embryonic myoblasts in their
responses to these factors. It is worth noting that, also after
3 days in vitro in absence of any treatment the percentage of
terminally differentiated cells is higher in embryonic cultures
(Fig. 5D), further confirming the accelerated differentiation of
embryonic myoblasts.
Gene expression profiling of undifferentiated embryonic, fetal
and C2C12 myoblasts
A genome-wide analysis of gene expression in embryonic
and fetal myoblasts was carried out using cRNA from freshly
sorted, uncultured, GFP+ cells (for a precise quantification of
the purity see Supplementary Table 3), hybridized on
Affymetrix Mouse Expression Array 430 A and B GeneChipset. This approach allowed the evaluation of the levels of
expression of more than 39,000 transcripts following hybridiza-
tion with approximately 45,000 probe sets. RNA was isolated
from embryonic and fetal myoblasts purified from more than
150 E11.5 embryos and more than 50 E16.5 fetuses,
respectively. The high number of embryos and fetuses used
should compensate for individual variability.
The transcriptomes of embryonic and fetal myoblasts
revealed many differences (Fig. 6A) and genes with a consistent
differential gene expression of more than 3-fold (fetal vs.
embryonic log2 ratio <−1.58 or >1.58) and an annotated
biological/molecular function or cellular localization (Gene
Ontology) were selected for further investigation. This
differential limited the set of candidates to 337 (275 with GO
annotated biological function) transcripts found to be more
highly expressed in embryonic myoblasts (Supplementary
Table 5) and to 237 (180 with annotated biological function)
in fetal myoblasts (Supplementary Table 6). TaqMan PCR was
used to validate differential expression of more than 40 genes.
The analysis was performed on material independently
collected from that used for the microarray (Supplementary
Table 3), ensuring a reliable biological replicate. The results,
although sometimes with different magnitude, reflected the
GeneChip data (Table 1, Supplementary Tables 5–6 and not
shown).
A gene expression profile of C2C12 myoblasts was also
performed. Not surprisingly, the entire transcriptome of the cell
line C2C12 is significantly different form that of embryonic and
fetal myoblasts, which both are primary cells and thus appeared
relatively more similar to each other (not shown). Nevertheless,
when only the 574 transcripts that were differentially expressed
in embryonic and fetal myoblast populations were considered, a
similarity appeared in their profile of expression between
C2C12 and fetal myoblasts (Fig. 6B). Interestingly C2C12
share many features with fetal myoblasts, including responses to
Fig. 5. Fetal (but not embryonic) myoblasts and C2C12 are intrinsically sensitive to TGFβ-1, TPA and BMP-4 mediated inhibition of differentiation. The inhibitory
effect of TGFβ-1 (A′, B′, C′), TPA (A″, B″, C″), BMP-4 (A‴, B‴, C‴), on purified embryonic (A), fetal (B) myoblasts (Mb) and C2C12 (C) differentiation was
determined by counting the number of nuclei within MyHC-positive cells (D′, D″, D‴). Note that after 3 days in vitro untreated embryonic cultures appeared more
differentiated in comparison to cultures of fetal myoblasts and C2C12 (D). (A, B, C) Scale bar, 100 μm. (D) Bars represent±SD. ***p<0.001, **p<0.01, *p<0.05 vs.
embryonic myoblasts.
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correlation between genetic program and behavior in vitro.
Classification of the genes upregulated in embryonic
myoblasts by GO terms revealed that transcription factors, as
well as genes implicated in embryonic development and pattern
specification, were highly represented compared with all genes
represented on the Mouse Expression Array 430. Conversely,
cell adhesion molecules were relatively highly represented
among the genes identified in fetal myoblasts. Finally a
significant number (∼20%) of differentially expressed genes
are involved in signal transduction (Fig. 6C).
In particular, the microarray analysis showed that several
genes involved in the TGFβ and BMP-4 signaling pathways
were relatively highly expressed in fetal myoblasts, such as the
proteoglycans Fibromodulin, Decorin and Biglycan, Latent
transforming growth factor-β binding proteins 3 and 4, Cited1
and TGFβ receptor II. Interestingly some of them (i.e., Decorin,
Biglycan, Ltbp3 and Tgfβ receptor II) were also relatively
highly expressed in the TGFβ and BMP-4 responsive C2C12
myoblasts (Supplementary Table 6). Moreover, the inhibitory
Smad6 and Smad7 which have an inhibitory effect on TGFβsuperfamily signaling (Imamura et al., 1997; Nakao et al.,
1997), were more highly expressed in embryonic myoblasts
(respectively 4.6 and 1.7 times; Table 1 and Supplementary
microarray data). These data provide important information for
the understanding of the molecular mechanisms governing the
different sensitivity to TGFβ and BMP-4 shown by embryonic
and fetal myoblasts. It has been previously reported that PkCθ is
more highly expressed during secondary myogenesis and when
overexpressed into embryonic myoblasts, is able to induce a
certain degree of sensitivity to TGFβ (Zappelli et al., 1996). The
microarray analysis revealed a high intensity of the hybridiza-
tion signal for PkCθ exclusively in the fetal population, but the
statistical algorithm used to elaborate the data indicated a
possible absence of PkCθ in both embryonic and fetal
myoblasts (Supplementary Table 6). In order to clarify this
discrepancy real-time PCR was performed, which showed an
enhanced expression (13.3-fold) of PkCθ in fetal compared
with embryonic myoblasts (Fig. 7E). The microarray analysis
also revealed that several members of the Notch signaling
pathway, including Notch1, Jagged1 and Deltex4 were
significantly more highly expressed in fetal myoblasts (Table
Fig. 6. Gene expression profiling of embryonic, fetal myoblasts. (A) Log scatter plots, where the x-axis is the embryonic myoblasts and the y-axis is the fetal myoblasts
signal. The diagonal lines represent the fold change thresholds. (B) Hierarchical clustering of genes expressed more than 3 times in embryonic or fetal myoblasts (see
Materials and methods). The number of upregulated (shaded of red) and downregulated (shaded of blue). Different shades indicate the signal log ratios between the
individual comparisons, and a color scale bar represents these values. Note that regarding these genes C2C12 is more similar to fetal myoblasts than to embryonic
myoblasts as indicated by the tree structure on the top. (C) Enrichment of genes encoding for developmental regulatory factors (GOID: 9790; 6350; 7389) and cell
adhesion molecules (GOID: 7155) in embryonic and fetal myoblasts, respectively. The left pie chart represents the percentage of genes with the indicated GO terms
among all the 275 genes with an annotated biological function expressed more than 3 times in embryonic myoblasts. The central pie chart represents the percentage of
genes with the indicated GO terms among all the 180 genes with an annotated biological function expressed more than 3 times in fetal myoblasts. The right pie chart
represents the percentage of genes with the indicated GO terms among all the 20451 genes with an annotated biological function on the Affymetrix Mouse Expression
Array 430. Note that more than 20% of the differentially expressed genes is involved in the signal transduction (GOID: 7165).
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were relatively high in embryonic myoblasts. The reported roles
of FGFs in controlling muscle differentiation (Olson, 1992) and
migration of embryonic myoblasts into the limb (Webb et al.,
1997) suggest an action through autocrine/paracrine mechan-
isms (Fox and Swain, 1993). It has also been reported that
PDGF is able to enhance the migration of the embryonic
myoblasts to the limb (Webb and Lee, 1997). The relatively
higher expression of both α and β PDGF receptors in
embryonic myoblasts detected by GeneChip analysis suggests
that fetal myoblasts could be less responsive to PDGF.
Interestingly, reduced PDGF binding by fetal myoblasts
compared with satellite cells has previously been reported in
the chick (Yablonka-Reuveni and Seifert, 1993), although
embryonic myoblasts were not included in that study. This and
the observations reported here, suggest that the different
myogenic populations differ in their ability to bind PDGF.
Many cell adhesion molecules, such as integrin-α7, -α8, -α4
and -α9, laminin-β2, -β4, -β and -β1, dystroglycan, Mcam,
CD44, CD34, Vcam-1 and Semaphorin 3d and 4g aredifferentially expressed between embryonic and fetal myoblasts
(see Table 1), offering a possible explanation for both the
different fusion ability and the preferential generation of
omotypic myotubes shown by the two population of myoblasts.
In particular the enhanced expression of Vcam-1 in fetal
myoblasts is consistent with a previous report, which proposed
that Vla-4/Vcam-1 interactions influence alignment of second-
ary myoblasts along primary myotubes and/or the fusion of
secondary myoblasts (Rosen et al., 1992). Conversely the
relatively high expression of several different laminins by fetal
myoblasts is consistent with the appearance of a basal lamina at
the beginning of secondary myogenesis (Kelly and Zacks,
1969). The expression of Integrin-α7 was further evaluated by
real-time PCR on purified embryonic and fetal population both
before and after differentiation in vitro (Fig. 7F). The level of
expression resulted 16.9- and 4.2-fold higher in fetal myoblasts
before and after differentiation, respectively, while only traces
were detected in the embryonic population before differentia-
tion (Supplementary Table 6). This differential expression of
Integrin-α7, which has been previously proposed as marker of
Table 1
Selected list of genes differentially expressed in embryonic or fetal undifferentiated myoblasts
(continued on next page)
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Table 1 (continued)
Genes more expressed in fetal myoblasts are depicted in grey.
PCR data were reported in brackets for the genes whose differential expression was confirmed by real-time PCR.
642 S. Biressi et al. / Developmental Biology 304 (2007) 633–651fetal myogenesis (George-Weinstein et al., 1993), is not
completely in agreement with data reported by Blanco-Bose
and Blau (2001), as they claimed a strong expression of
Integrin-α7 protein in undifferentiated embryonic myoblasts.
Moreover microarrays indicate that many genes encoding
components of the extracellular matrix were more highly ex-
pressed in fetal myoblasts, including several collagenous and
non-collagenous proteins (Table 1). Interestingly, the hemato-
poietic marker CD45 resulted absent in both embryonic and
fetal myoblasts (Supplementary Fig. 13 and Supplementary
microarray data) indicating that they are not hematopoietic in
origin.
A small number of transcription factors were more highly
expressed in fetal compared with embryonic myoblasts,including all four members of NfI family (Funk and Wright,
1992) and the proliferation/differentiation regulators Fos-b and
Jun-b (Li et al., 1992) (Table 1). However, a greater number of
transcription factors were more highly expressed in embryonic
myoblasts. These include Pax3 which is known to control the
delamination and migration of somitic muscle progenitors to the
limb bud (Relaix et al., 2004) and is able to activate MyoD
expression as does Myf5 in the embryonic body (Tajbakhsh et
al., 1997). Differential expression of Pax3 in embryonic and
fetal populations, both before and after differentiation, was
confirmed by quantitative real-time PCR (Fig. 7A). Interest-
ingly, several genes whose expression had previously been
reported to be directly or indirectly linked to Pax3 expression,
were also relatively higher in the embryonic population (Table
Fig. 7. Pax3, Paraxis, Muscle Creatin Kinase (MCK), PkCθ and Integrin-α7 are differentially expressed in embryonic and fetal myoblasts. The expression of Pax3 (A),
c-Met (B), Paraxis (C), MCK (D), PkCθ (E) and Integrin-α7 (F) has been evaluated by real-time PCR on the embryonic population freshly isolated (Embr Mb) or after
3 days in vitro (Embr Mt) and on the fetal population freshly isolated (Fet Mb) or after 3 or 6 days (Fet Mt) in vitro.
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mentary microarray data) (Ridgeway and Skerjanc, 2001), and
Caderin11 (Markus et al., 1999). In addition, GeneChip
analysis revealed also that Meox2 which has been shown to
be an important regulator of limb myogenesis (Mankoo et al.,
1999) and which is able to physically interact with Pax3 in vitro
(Stamataki et al., 2001) was more highly expressed in
embryonic myoblasts. Perhaps surprisingly, the expressions of
the established Pax3 targets c-Met (Epstein et al., 1996) and
Six-1 (Ridgeway and Skerjanc, 2001) were only slightly greater
than in fetal myoblasts (Fig. 7B and Supplementary microarray
data), where Pax3 transcripts were almost undetectable,
suggesting that their expression may also depend upon different
regulators. Interestingly, fetal myoblasts show higher expres-
sion of the Pax3 paralogue Pax7 (2.7 times; Supplementary
microarray data). Other genes such as Follistatin, MdfI, Ctgf,
Id2, Twist and Mef2C that regulate muscle differentiation were
found to be relatively highly expressed in embryonic myoblasts,as were several molecules which are known to be involved in
skeletal muscle development or somitogenesis such as Ephrin
B2, Uncx4.1, FoxC1 and FoxC2 and several Hox genes (Table
1 and Supplementary Table 5).
Functional Notch signaling is required for TGFβ, TPA and
BMP-4 induced inhibition of fetal myoblasts differentiation
Fetal myoblasts differ to their embryonic counterparts for
the different sensitivity to TGFβ, TPA and BMP-4 (see above).
Interestingly, crosstalk between TGFβ superfamily and Notch
signaling pathways has been recently reported for a few cellular
types, including C2C12 and satellite cells (Blokzijl et al., 2003;
Dahlqvist et al., 2003; Itoh et al., 2004). As several members of
the Notch pathway resulted strongly more expressed in fetal in
comparison to embryonic myoblasts (see above), we decided to
investigate the possible interplay between TGFβ, TPA, BMP-4
and Notch signaling in fetal myoblasts. With this aim we added
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which hinders Notch intracellular domain release (Karlstrom et
al., 2002). After treatment with L-685,458 the differentiation
block induced by TGFβ, TPA or BMP-4 was substantially
reversed and the number of MyHC+ cells increased respec-
tively by 4.1- (from 11.6% to 44.1%), 2.3- (from 19.5% to
45.8%) and 2.5-fold (from 22.5% to 56.3%) compared with
when TGFβ, TPA or BMP-4 were added with the control
solvent (DMSO) (Figs. 8C–I). The addition of L-685,458 in
absence of TGFβ, TPA or BMP-4 also increased the percentage
of MyHC+ cells, although at minor extent (1.6-fold, from
32.0% to 50.3%) (Figs. 8A, B and I). These observations
strongly suggest that a functional Notch signaling is required
for TGFβ, TPA and BMP-4 induced inhibition of fetal myo-
blasts differentiation.
Hox code is expressed in embryonic, but not in fetal myoblasts
Somite identity is specified by the combinatorial expression
of Hox genes, usually referred to as the “Hox code” (Burke,Fig. 8. Effect of Notch signaling on fetal myoblasts response to TGFβ-1, TPA or BMP
(DMSO; A, C, E, G) and differentiated in the presence or absence of TGFβ-1 (C, D)
determined by counting the number of nuclei within MyHC-positive cells after imm
Bars represent±SD. **p<0.01 vs. the same treatment in absence of L-685,458.2000). The microarray analysis revealed that almost all Hox
genes are expressed in embryonic myoblasts, most of them at
significantly higher levels than in fetal myoblasts (Supplemen-
tary Table 5 and Supplementary microarray data). To determine
whether Hox genes potentially carry “positional information” in
myoblasts, relative expression along the cranio-caudal gradient
was investigated. Embryonic myoblasts were isolated from
different axial levels of Myf5GFP-P/+ embryos at the onset of
primary myogenesis (E10.5). The head and limb buds were
removed to avoid contamination with migratory myoblasts and
the embryo was cut into three segments; an anterior portion
containing the first 13–14 somites (from the neck to the
posterior border of the forelimb); a central portion correspond-
ing to the thoracic somites between the anterior and posterior
limb buds; and a posterior portion extending caudally from the
anterior border of the hind limb buds (Fig. 9A). GFP-expressing
myoblasts were sorted from each segment and the transcripts of
13 representative members of 12 different Hox paralogues were
quantified by real-time PCR (Fig. 9B). The pattern of expres-
sion obtained was comparable to that previously documented-4. Fetal myoblasts were treated with of L-685,458 (B, D, F, H) or control solvent
, TPA (E, F) or BMP-4 (G, H). Scale bar, 100 μm. The effect of L-685,458 was
unostaining with anti-MyHCs antibodies. DAPI was used to stain the nuclei (I).
Fig. 9. Embryonic myoblasts have a Hox code. (A) The expression level of 13 Hox genes belonging to different paralogue groups has been evaluated by real-time PCR
on myoblasts isolated at different axial levels from E 10.5 MyfGFP-P/+ embryos: An→ from neck until posterior part of the limb (somite 14); Ce→ interlimb level;
Po→ from anterior part of the limb level until tail (fore and hind limb were dissected away). (B) The level of expression of each Hox gene is represented by the
correspondingΔCt value (ΔCt >25 is arbitrarily intended as absent). The Hox genes expression boundaries identified along the anterior–posterior axis in the isolated
myoblasts from correlate with those documented in the somites (Burke et al., 1995; Vogels et al., 1990). Abbreviations used: FL: forelimb; HL: hind limb; H: heart.
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consistent with the existence of a Hox code specifically in
embryonic myoblasts.
Differential expression of muscle-structural genes in
differentiated embryonic and fetal myotubes
Previous studies reported the differential expression of a
small number of genes in embryonic and fetal myotubes
(Barbieri et al., 1990; Ferrari et al., 1997; Zappelli et al., 1996).
Here, pure populations of embryonic and fetal myoblasts from
Myf5GFP-P/+ mice were induced to differentiate in vitro in the
absence of other cell types and therefore in an environment free
of external cellular influences. A gene expression profile was
carried out on samples prepared after 3 days of differentiation in
vitro. The expression of 81 genes, chosen for their known
involvement in myogenesis and muscle function, was evaluated
by quantitative, real-time PCR (Table 2 and Supplementary
Table 4). Thirteen genes were identified as being relatively
highly expressed in fetal myotubes (>2 times; fetal vs.
embryonic log2 ratio >1), and 27 were identified in embryonic
myotubes (>2 times; embryonic vs. fetal log2 ratio <−1),
consistent with different intrinsic genetic programs in the two
populations after differentiation (Table 2). Embryonic and fetal
myotubes were found to differ in the expression of genes
encoding a number of myofibrillar proteins, includingMyHC-β,
fast/neonatal MyHC, subunits of the troponin complex (slow/
cardiac troponin C, cardiac troponin I, slow troponin I, slow
troponin T, fast troponin T), myosin light chain isoforms
(MyLC1sa, MyLC1s/v, MyLC2s/v), tropomyosin isoforms (fast
and slow α-tropomyosin), α-actinin2, and telethonin. Genes
encoding the metabolic enzymes MCK (Ferrari et al., 1997),
β-Enolase (Barbieri et al., 1990) and lactate dehydrogenase 2
and Parvalbumin, Calsequestrin 1 and Serca1, involved in
excitability and excitation–contraction coupling, were all rela-
tively highly expressed in fetal myotubes. These observations
are consistent with our previous observation that essentiallyonly fetal myotubes spontaneously contract in vitro. In addition,
differential expression was found for genes involved in cell
adhesion, signal transduction and muscle differentiation, such
as Integrin-α7, PkCθ, Berf-1, Foxo1, Nfatc4, follistatin, myos-
tatin, Mrf4 and Eya2. Interestingly, some of these genes were
also differentially expressed in undifferentiated myoblasts, i.e.,
follistatin, Eya2, telethonin, α-actinin2, Nfatc4, MCK, PkCθ
and Integrin-α7 (Figs. 7D–F).
Among the 81 genes evaluated, 12 are known to be more
highly expressed in adult slow contracting Type I fibers, and
other 12 in fast contracting Type II fibers (Bottinelli and
Reggiani, 2000). Eleven of the 12 assayed genes known to be
predominantly expressed in the slow fibers were more highly
expressed in embryonic myotubes (for 8 of them, expression
was more than 2-fold greater than in fetal myotubes). In
contrast, 8 of the 12 genes characteristic of fast fibers were more
highly expressed in myotubes derived from the fetal population
(5 of them, more than 2-fold greater) (Fig. 10). These
observations suggest that each fiber type is, at least in part,
determined by intrinsic programming of different myogenic
precursor populations and that primary (embryonic) and
secondary (fetal) fibers possess a genetic signature that can
influence the eventual adult muscle fiber physiology.
Discussion
Isolation of pure populations of embryonic and fetal myoblasts
Until now, it was possible to study embryonic and fetal
myoblasts only in culture either in the presence of other cell
types (mainly fibroblasts), or at clonal density under conditions
that necessarily select for a clonogenic minor sub-population
(DiMario and Stockdale, 1995). Unlike avian myoblasts (Miller
et al., 1999), murine embryonic myoblasts (and to a lesser
extent fetal myoblasts) form clones consisting of only a few
cells that cannot be expanded further in vitro for biochemical
and molecular analysis. In this study, a cell-sorting method for
Table 2
Muscle characteristic genes more expressed (>2 times) in embryonic or fetal myotubes
Genes more expressed in fetal myotubes are depicted in grey. Reference for fiber type specificity: Bottinelli and Reggiani, 2000.
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and fetal myoblasts was developed using a knock-in mouse with
the GFP gene targeted into the Myf5 locus (Kassar-Duchossoy
et al., 2004). This has made it possible to isolate stage-specific,highly purified myogenic populations. Although FACS-based
methods are available for the purification of adult human
(Webster et al., 1988), rat (Kaufman and Foster, 1988) and
mouse (Blanco-Bose et al., 2001) satellite cells, this is the first
Fig. 10. Evaluation of the expression of slow and fast fibers specific genes
discloses a correlation between fetal myotubes and fast fibers and between
embryonic myotubes and slow fibers. Transcript levels of 12 slow (1–12)- and
12 fast-specific (A–L) genes (see Table 2 and Supplementary Table 4) were
evaluated by real-time PCR on purified populations after 3 days of
differentiation in vitro. The level of expression of each gene in the embryonic
(ordinate) and fetal (abscissa) population is represented by theΔCt value, which
is inversely and exponentially correlated to the amount of transcripts. Note that
the majority of the slow-specific genes are expressed at higher level in
embryonic population, whereas most of the fast-specific genes are more
abundant in the fetal population. Bars represent±SD between 4 technical
replicates.
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to isolate murine embryonic and fetal myoblasts.
Differentiation/Proliferation characteristics of embryonic and
fetal myoblasts in vitro
The data presented here demonstrate unequivocally that
embryonic and fetal myoblasts are distinct populations of
myogenic cells with different morphologies and fusion
characteristics in vitro. These observations confirm previous
reports on muscle colony forming cells and unpurified cell
preparations isolated from chicken (Bonner and Hauschka,
1974), rat (Pin and Merrifield, 1993), mouse (Cusella-
DeAngelis et al., 1992) and human (Hauschka, 1974). More-
over the co-culture experiments presented here indicate that
although murine embryonic and fetal myoblasts can fuse to each
other, as previously reported for rat myoblasts (Pin and
Merrifield, 1997), they have a preference for omotypic fusion.
This observation further supports the conclusion that embryonic
and fetal myoblasts are distinct populations that behave
differentially also when cultured together in the same dish.
Embryonic myoblasts differentiate more readily than their
fetal counterparts in vitro. Since differentiation is normally
associated with cell cycle exit (Lassar et al., 1994) it is not
surprising that embryonic myoblasts also show reduced
proliferation (as assayed by BrdU incorporation) and clono-genic ability. Notably, when evaluated by FACS analysis after
Hoechst staining, freshly isolated populations of embryonic and
fetal myoblasts were similar with regard to the fraction of
proliferating cells (∼30% of the cells in S-G2-M; Fig. 1),
suggesting that neither population is more differentiated than
the other at the moment of isolation. Nevertheless, embryonic
myoblasts have a greater propensity to differentiate compared to
their fetal counterparts. From a teleological point of view, the
increased tendency to differentiation shown by embryonic
myoblasts may relate to the early formation of functional
muscle fibers, needed by the embryo to move, and, for lower
vertebrates, to feed and escape from predators. This strategy
may have originally been adopted as a survival mechanism for
embryos developing outside of a protected environment as in
birds and mammals, and this characteristic may have been
maintained during amniote evolution.
Differential responses of embryonic and fetal myoblasts to
regulatory molecules
Vertebrate myogenesis is thought to occur in multiple
phases involving different classes of progenitors, albeit direct
lineage evidence for this notion is lacking. This enables the
maintenance of a pool of precursors to cope with growth while
at the same time, generating contracting, post-mitotic skeletal
muscle fibers to allow early movements of the embryo. A
possible mechanism to ensure that one class of myoblasts will
differentiate in an environment that is permissive for the
proliferation of other classes may be based on the inability of
the former to respond to growth factors and/or to molecules
that inhibit differentiation. A number of years ago, we
proposed that TGFβ might influence the process of primary
fiber formation in vivo, by inhibiting the differentiation of
fetal, but not of embryonic myoblasts (Cusella-DeAngelis et
al., 1994). Data presented here demonstrate that embryonic
and fetal myoblasts are indeed intrinsically different in their
response to TGFβ supporting this hypothesis. The two
populations of myoblasts also respond differently to BMP-4,
further suggesting that multiple growth factors may cooperate
to precisely regulate the timing of myoblast differentiation.
There also appears to be a certain degree of redundancy
among different BMP and different TGFβ isoforms, suggest-
ing that this regulatory mechanism may be essential for correct
muscle development. TPA also inhibits the differentiation of
C2C12 and fetal, but not embryonic, myoblasts and although
not normally present in the embryo, it may mimic the action of
natural endogenous molecules that activate PKC. It was
previously reported that satellite cells are insensitive to TPA
(Cossu et al., 1988). The sensitivity of C2C12 myoblasts to
TPA is therefore surprising, as this line was originally isolated
from regenerating adult (2-month-old) skeletal muscle and
thus considered a model of satellite cells (Blau et al., 1983).
The molecular mechanisms that mediate the intracellular
response of fetal myoblasts to TGFβ/BMP-4/TPA remain
poorly understood, although the protein kinase C isoform
PkCθ is involved (Zappelli et al., 1996). When the expression
of PkCθ in purified myoblast populations was accurately
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high expression in undifferentiated fetal myoblasts (when they
are sensitive to the action of the TGFβ/BMP-4/TPA),
consistent with previous reports of expression during second-
ary myogenesis (Zappelli et al., 1996). In addition to PkCθ,
microarray analysis revealed differential expression of other
members of the TGFβ superfamily pathway (Decorin,
Byglican, Cited1, Ltbps, Smad6 and Smad7) in the embryonic
and fetal myoblasts. Moreover, we showed that several
positive modulators of the Notch pathway resulted as
upregulated in fetal myoblasts. By using the γ-secretase
inhibitor L-685,458, we provide here evidence that in fetal
myoblasts, functional Notch signaling is necessary for TGFβ,
TPA and BMP-4 mediated inhibition of myogenic differentia-
tion, in agreement with previous reports on C2C12 and satellite
cells (Blokzijl et al., 2003; Dahlqvist et al., 2003). Although
mechanisms of Notch signaling not needing the release of the
NICD fragment and acting in a CSL-independent way have
been proposed (Bush et al., 2001), the data reported here
indicate that this TGFβ, TPA and BMP-4 induced block of
differentiation requires the cleavage of Notch.
Pax3 and Pax7 in embryonic and fetal myoblasts
Pax3 and its paralogue Pax7 have been implicated in the
specification of progenitor cells for the myogenic program.
Recently, attempts have been made to elucidate both common
and distinct features for these paralogues. It has been suggested
that all cells of the myogenic lineage (embryonic and fetal
myoblasts and satellite cells) are derived from a Pax3/7-positive
population of myogenic progenitors resident in the dermomyo-
tome (Kassar-Duchossoy et al., 2005; Relaix et al., 2005;
Schienda et al., 2006). These progenitors can differentiate into
skeletal muscle fibers or remain as a reserve cell population
within the growing muscle mass during peri- and postnatal
stages. Pax3 and Pax7 are both expressed in embryonic
myoblasts and satellite cells, although not necessarily in the
same cell: in particular, Pax3 seems to be expressed only in a
subset of adult satellite cells (Montarras et al., 2005). Recent
studies have shown that Pax3 and Pax7 have both distinct and
overlapping functions in adult regenerative myogenesis (Kuang
et al., 2006; Relaix et al., 2006) and during embryonic
myogenesis (Relaix et al., 2004). However, while the role of
Pax genes in embryonic and postnatal myogenesis have been
the subject of intense investigation, their function during fetal
myogenesis remains unexplored. The data presented here show
that essentially only Pax7 is expressed in fetal myoblasts.
Although analysis at the single cell level was not carried out to
exclude the possible expression of Pax3 in a small subset of fetal
myoblasts, these data show that, as in satellite cells, Pax7
predominates during fetal myogenesis, in agreement with a
recently published immunohistochemical analysis (Horst et al.,
2006). Interestingly, the satellite compartment and adult muscle
regeneration are severely affected in the absence of Pax7,
whereas fetal myogenesis appears unaffected (Seale et al., 2000)
suggesting that compensatory mechanisms may act at the fetal
stage, but not postnatally.In addition to Pax3 itself, undifferentiated embryonic
myoblasts also show relatively enhanced expression of several
genes directly or indirectly linked to Pax3 expression, such as
Meox1, Eya2 and Cadherin11. In contrast, expression levels of
the Pax3 targets Six1 and c-Met are similar in embryonic and
fetal myoblasts (Fig. 7B and Supplementary microarray data).
c-Met is widely expressed by satellite cells, suggesting that
activation of c-Met is Pax3-independent at the fetal and
postnatal stage. Although Pax7 would be an obvious candidate,
inefficient activation of c-Met during embryonic myogenesis
occurs when Pax3 is replaced by Pax7 using a gene targeting
strategy (Relaix et al., 2004).
Other genes such as Meox2, Paraxis, FoxC1 and 2, Twist,
Uncx4.1 and Ephrin B2 also show relatively high expression
in embryonic compared with fetal myoblasts. Interestingly in
Meox1/Meox2 double knockout embryos reduced expression
of Pax3, Paraxis and Twist has been reported (Mankoo et al.,
2003) and in FoxC1/FoxC2 double knockout mice there is a
complete absence of somitic expression of Paraxis, Ephrin B2
and Uncx4.1 (Kume et al., 2001). Taken together, these data
strongly suggest the existence of a myogenic cascade that is
active in the embryonic, but not in the fetal population of
myoblasts.
Expression of a Hox code in embryonic myoblasts
Although morphologically very similar, somites differentiate
into distinct mesodermal tissues, depending on their axial level.
The identity of the somite is specified by a unique expression
profile of Hox genes, generally referred as “HOX code” (Burke,
2000). Classical transplantation experiments have shown that
this segmental identity is able to influence the fate of
sclerotomal (vertebrae and ribs) and non-myogenic dermomyo-
tomal (back dermis and scapula) derivatives of the somite
(Ehehalt et al., 2004; Jacob et al., 1975; Kieny et al., 1972;
Mauger, 1972). In contrast, it was generally accepted for many
years that somitic myogenic precursors are completely naïve
and do not possess positional information, depending exclu-
sively on extrinsic cues to direct site-specific fate. This view
was based on classical embryological experiments in the chick
(Christ et al., 1977), in which somites were heterotopically
transplanted at the limb level such that the generation of graft-
derived appendicular muscles could be observed, but was
recently challenged by Alvares et al. (2003). Although several
studies had already suggested that myogenic precursors in the
somite could also have positional identity (Donoghue et al.,
1992a; Donoghue et al., 1992b; Grieshammer et al., 1992;
Murakami and Nakamura, 1991), Alvares and coworkers
clearly showed that the ability to generate either migratory
(Lbx1+) or non-migratory (Lbx1−) muscle precursors is
dependent upon intrinsic properties of the somite from which
they were derived. These studies also showed that the limbs
contain a potent signaling mechanism (i.e., FGFs) that can
override the non-migratory program of flank somites and induce
expression of the migration marker Lbx1. Further, the somitic
predisposition towards a particular myogenic program (migra-
tory or non-migratory) was shown to depend, directly or
649S. Biressi et al. / Developmental Biology 304 (2007) 633–651indirectly, on Hox genes. These findings show that results
obtained by heterotopic grafting into the limb area (Christ et al.,
1977) do not necessarily apply to other axial levels and
conclusively demonstrate that the axial identity of the somites,
conferred by HOX genes, can also determine the fate of skeletal
muscle precursors. However, whether this positional informa-
tion is intrinsically encoded in myoblasts or in neighboring cells
within the same somite, remained unknown.
Data presented here demonstrate that embryonic myoblasts
isolated from different positions along the antero-posterior axis
are characterized by a pattern of Hox genes expression very
similar to that documented for whole somites (Burke et al.,
1995; Vogels et al., 1990), clearly indicating that, in vivo,
embryonic myoblasts express themselves a HOX code, and thus
presumably posses direct positional information. These data are
in agreement with the work of Alvares et al. (2003) and,
moreover, show for the first time, that a HOX code exists in the
embryonic myoblasts, which thus express HOX genes accord-
ing to their cranio-caudal position. Further experiments in
which myoblasts are purified by FACS from specific axial
levels and then heterotypical transplanted would definitively
show if the myoblast-specific Hox code reported here carries the
positional information as previous experiments involving
transplantation of the dermomyotomal compartment of the
somite suggest (Fomenou et al., 2005). In contrast, fetal
myoblasts do not express Hox genes and are probably oriented
by pre-existing primary fibers (Cossu and Biressi, 2005).
“Pre-determination” of the fast and slow fiber phenotype
Few genes are known to be differentially expressed between
embryonic and fetal myotubes, including PkCθ and the muscle-
specific slow MyHC, β enolase and MCK (Barbieri et al., 1990;
Ferrari et al., 1997; Zappelli et al., 1996; Zhang et al., 1998).
Using pure populations of embryonic and fetal myoblasts, it is
now possible to analyze the expression of other, not necessarily
muscle-specific, genes. Using real-time PCR, 40 genes were
identified which are expressed more highly (>2 times) in one or
the other population (Table 2). This analysis represents an
important step towards the characterization of primary and
secondary fibers. Notably, many of these differentially
expressed transcripts correspond to genes for which differential
expression has been reported between adult slow (Type I) and
fast (Type II) fibers (Bottinelli and Reggiani, 2000). It has
already been proposed that the slow contracting Type I fibers
and the fast contracting Type II fibers may be derived from
prenatal primary and secondary fibers, respectively. This
hypothesis is mainly based on the differential expression of
slow and fast MyHC isoforms in embryonic and fetal myotubes,
respectively (Kelly and Rubinstein, 1980). However, it is not
known whether primary and secondary fibers possess a genetic
signature that can influence subsequent muscle fiber physiology
in the adult. Although other influences like exercise, hormones,
local factors and innervation also play an important role in
modulating muscle fiber type phenotype (Wigmore and Evans,
2002), data reported here strongly suggest the existence of a
slow program in embryonic myoblast and of a fast program infetal myoblasts. Likely, all the abovementioned mechanisms
may cooperate in the establishment of the various subtypes of
adult muscle fibers.
Concluding remarks
Thanks to a newly developed cell-sorting method it was
possible to study murine embryonic and fetal myoblasts as
purified populations. in vitro, the two classes of myoblast show
intrinsically different fusion, proliferation and response to
TGFβ and TPA, consistent with previous reports. Furthermore,
a previously undescribed differential sensitivity to BMP-4 and
accelerated rate of differentiation were observed. Microarray
and real-time PCR analysis revealed a number of differentially
expressed genes between the two populations, including several
transcription factors and a number of contractile proteins, both
before and after differentiation.
Collectively, these data clearly demonstrate that embryonic
and fetal myoblasts correspond to intrinsically different
myogenic lineages and represent a starting point for future
studies to define the molecular basis of asynchronous skeletal
muscle development.
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